Assistance of Artificial Intelligence in Diagnosis of Vitreoretinal Lymphoma on Optical Coherence Tomography
Vitreoretinal lymphoma (VRL) remains a diagnostic challenge due to its scarce prevalence, and delayed diagnosis usually results in blindness and even fatal outcomes. Herein, an artificial intelligence (AI) system is developed to identify VRL among 16 retinal diseases and conditions on optical cohere...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Advanced Intelligent Systems |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/aisy.202400500 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Vitreoretinal lymphoma (VRL) remains a diagnostic challenge due to its scarce prevalence, and delayed diagnosis usually results in blindness and even fatal outcomes. Herein, an artificial intelligence (AI) system is developed to identify VRL among 16 retinal diseases and conditions on optical coherence tomography (OCT) images with the cross‐subject meta‐transfer learning (CS‐MTL) algorithm. Extensive experiments of few‐shot VRL recognition tasks prove the robustness of our model on 1‐, 3‐, and 5‐shot scenarios, achieving an F1 score of 0.8697 to 0.9367. The superiority of the model is shown with a higher F1 score (0.9310) compared with other state‐of‐the‐art algorithms (0.5487–0.9018) and three doctors whose clinical experiences range between 3 to 10 years without the help of the CS‐MTL (0.7773–0.8949). AI assistance significantly improves the F1 scores of doctors by 6.16–14.46% (p < 0.001). Moreover, the F1 scores of AI‐assisted senior doctor and retinal specialist (0.9414 and 0.9500), but not the junior doctor (0.8897), exceed that of the CS‐MTL (0.9310). This study presents a promising approach for aiding in the diagnosis of VRL on retinal OCT images and may provide a novel insight into the collaboration of doctors with AI techniques, resulting in reducing the risk of diagnostic delays of rare diseases. |
|---|---|
| ISSN: | 2640-4567 |